Walking along Paris’ famed Champs-Elysees this week, actor Jonathan Roumie, who plays Jesus in the television series The Chosen, tells CBN News that he’s humbled by how God is using the show to touch millions of people around the world.
“Do you often pinch yourself realizing the magnitude of the role that you are playing and how well the show has done?” CBN News asked.
“I don’t know if I pinch myself, I’m more ‘bow my head to the ground’ because I never feel that I’m worthy of the things that are happening as a result,” Roumie says.
Three years after its premiere episode, the series now hits television screens for the first time across France airing on one of this country’s top TV channels.
“To be on a major network is a first,” said Katherine Warnock, one of the show’s producers. “We love our platform, we love having a free app that’s available to the whole world, but to be embraced by Canal + has been such an honor.”
Roumie and cast members joined 500 people for a showing of The Chosen at a Paris movie theater ahead of next week’s broadcast, many watching it for the first time.
“The intimacy between the disciples and Jesus, I like that very much,” said one attendee.
“It was different from other films about Jesus, it was just fantastic I can say,” said another.
The Chosen is the first-ever multi-season TV show about the life of Jesus. And even though it’s free to watch on their app, fans have given more than $40 million towards the production budget, making it the largest crowd-funded media venture in entertainment history.
Sixteen episodes of The Chosen have so far been translated into 50 languages. And as of today’s taping, more than 321 million people around the world have watched the series.
For the rest of this article, visit our content partners at cbnnews.com. {eoa}
Reprinted with permission from CBN.com. Copyright © 2021 The Christian Broadcasting Network Inc. All rights reserved.
Read articles like this one and other Spirit-led content in our new platform, CHARISMA PLUS.
See an error in this article?
To contact us or to submit an article
